TAMI MCKINNEY: Open Payments
NPI 1528470994 · MOUNT AIRY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 71 payments from 16 companies in 2025. Trend: 2023 $17 · 2024 $592 · 2025 $1,473
Food & beverage: $1,465Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $324 |
| GENZYME CORPORATION | 9 | $230 |
| Organon LLC | 15 | $214 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Regeneron Healthcare Solutions, Inc. | 5 | $128 |
| Janssen Biotech, Inc. | 3 | $90 |
| PFIZER INC. | 3 | $78 |
| Galderma Laboratories, L.P. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Incyte Corporation | 2 | $35 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, RINVOQ, VTAMA, TREMFYA, CIBINQO, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
